- Report
- August 2023
Japan, United States, ... Japan, United States, Europe
From €1441EUR$1,500USD£1,232GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2642EUR$2,750USD£2,259GBP
- Report
- December 2021
Global
From €4660EUR$4,850USD£3,984GBP
- Report
- February 2020
- 203 Pages
Japan, United States, ... Japan, United States, Europe, Global
From €4324EUR$4,500USD£3,697GBP
- Report
- July 2019
- 835 Pages
Global
From €8167EUR$8,500USD£6,982GBP
From €817EUR$850USD£698GBP
- Report
- February 2022
- 137 Pages
Global
From €4324EUR$4,500USD£3,697GBP
- Report
- July 2023
- 180 Pages
Global
From €5764EUR$5,999USD£4,928GBP
The Lyme Disease Test market is a subset of the larger Infectious Disease Testing market. Lyme Disease is a bacterial infection caused by the Borrelia burgdorferi bacteria, which is transmitted to humans through the bite of an infected black-legged tick. Lyme Disease is the most commonly reported vector-borne illness in the United States, and is also found in Europe, Asia, and Australia. Diagnosis of Lyme Disease is typically done through a combination of physical examination, medical history, and laboratory testing. Tests used to diagnose Lyme Disease include ELISA, Western Blot, and PCR.
Companies in the Lyme Disease Test market include Abbott Laboratories, Bio-Rad Laboratories, DiaSorin, Hologic, and Quest Diagnostics. Show Less Read more